Professor and Senior Staff Scientist at The Jackson Laboratory.
The Harrison research group investigates aging in mouse models, focusing on processes that have the potential to retard aging and prolong health. For example, one line of research investigates mutations that reduce IGF-1 and insulin function. Such mutations can increase life span and delay certain aspects of aging, especially development of cancer. We also demonstrated through an Intervention Testing Program (ITP) that rapamycin, an inhibitor of the mTOR pathway, extends median and maximal lifespan in mice. We are continuing our ITP research.
Our other focus area is on hematopoietic stem cells (HSCs) and other adult stem cells, which constantly proliferate and differentiate to maintain tissue functions throughout life. If aging exhausts the function of adult stem cells, the balance between damage and repair is disrupted and tissue functions become defective. Our group has found that genetic mechanisms protect hematopoietic stem cells from exhaustion in some mouse strains, and we are working to define the specific mechanisms. Our long-term goal is to promote healthful aging in humans, either by delaying normal aging processes or by minimizing or eliminating diseases of aging.
Visit website: https://www.jax.org/research-and-faculty/faculty/dave-harrison
The Jackson Laboratory (JAX)
- Independent, nonprofit biomedical research institution specialized in genetics, genomics and mouse models of disease.
David Harrison News
Is This the Anti-Aging Pill We’ve All Been Waiting For?
MIT Technology Review - 28-Mar-2017
Novartis sought to see whether giving low doses of everolimus to people over 65 increased their r...